ABCC1 and cancer: Therefore, targeting FSIP1 can be a “one stone two birds” strategy since blocking FSIP1 inhibits cancer cell proliferation and promotes apoptosis6, and can also destabilize MRP1 and sensitize cancer cells to chemotherapeutic agents.